LELIA NICHOLS: Open Payments
NPI 1164658142 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,984 in 154 payments from 23 companies in 2025. Trend: 2023 $3,824 · 2024 $3,689 · 2025 $2,984
Food & beverage: $2,984
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $403 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $326 |
| Regeneron Healthcare Solutions, Inc. | 10 | $278 |
| Arcutis Biotherapeutics, Inc. | 23 | $241 |
| Galderma Laboratories, L.P. | 11 | $206 |
| Novartis Pharmaceuticals Corporation | 9 | $194 |
| Janssen Biotech, Inc. | 6 | $178 |
| Lilly USA, LLC | 8 | $174 |
| GENZYME CORPORATION | 7 | $171 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 9 | $157 |
Products named: DUPIXENT, SKYRIZI, Zoryve, ILUMYA, NEMLUVIO, TREMFYA, TALTZ, SILIQ.
Industry payments across TX — which companies pay providers there.
